|
TMED5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.42350000001501E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.803750E-04 |
| Normal-vs-Stage2 |
5.312300E-02 |
| Normal-vs-Stage3 |
2.37960000037951E-07 |
| Normal-vs-Stage4 |
7.44789999673756E-08 |
| Stage1-vs-Stage2 |
6.410600E-01 |
| Stage1-vs-Stage3 |
1.363620E-02 |
| Stage1-vs-Stage4 |
6.741700E-03 |
| Stage2-vs-Stage3 |
7.214300E-02 |
| Stage2-vs-Stage4 |
2.347600E-02 |
| Stage3-vs-Stage4 |
3.945000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.05540000000715E-06 |
| Normal-vs-AfricanAmerican |
5.528300E-02 |
| Normal-vs-Asian |
4.06240000000446E-05 |
| Caucasian-vs-AfricanAmerican |
4.430000E-01 |
| Caucasian-vs-Asian |
6.259200E-01 |
| AfricanAmerican-vs-Asian |
3.360800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.14949999996394E-06 |
| Normal-vs-Female |
3.60460000000673E-05 |
| Male-vs-Female |
1.044190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.895990E-03 |
| Normal-vs-Age(41-60Yrs) |
7.99960000019695E-07 |
| Normal-vs-Age(61-80Yrs) |
1.64451999999926E-05 |
| Normal-vs-Age(81-100Yrs) |
2.053700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.754400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.539500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.924400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.721600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.323600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.820200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.177800E-03 |
| Classical-VS-Follicular |
2.179000E-01 |
| Classical-VS-Other |
3.605400E-01 |
| Classical-VS-Normal |
1.384950E-04 |
| Tall-VS-Follicular |
1.544770E-03 |
| Tall-VS-Other |
7.774200E-01 |
| Tall-VS-Normal |
1.30969999956321E-07 |
| Follicular-VS-Other |
2.645000E-01 |
| Follicular-VS-Normal |
2.703600E-02 |
| Other-VS-Normal |
5.837100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.39329999999605E-05 |
| Normal-vs-N1 |
4.75860000292982E-08 |
| N0-vs-N1 |
1.477760E-02 |
|
|
